4//SEC Filing
MACARTNEY LAWSON 4
Accession 0001209191-23-030794
CIK 0001607678other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 6:30 PM ET
Size
8.6 KB
Accession
0001209191-23-030794
Insider Transaction Report
Form 4
MACARTNEY LAWSON
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.00001 per share
2023-05-16$1.19/sh+16,000$19,040→ 63,965 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-05-16−16,000→ 0 totalExercise: $1.19From: 2018-01-03Exp: 2027-01-03→ Common Stock (16,000 underlying) - Sale
Common Stock, par value $0.00001 per share
2023-05-16$24.00/sh−16,000$384,000→ 47,965 total
Footnotes (1)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Documents
Issuer
Viking Therapeutics, Inc.
CIK 0001607678
Entity typeother
Related Parties
1- filerCIK 0001606831
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 6:30 PM ET
- Size
- 8.6 KB